BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7806116)

  • 1. [Neuron-specific enolase as a tumor marker].
    Biran H
    Harefuah; 1994 Dec; 127(11):500-2. PubMed ID: 7806116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer].
    Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525
    [No Abstract]   [Full Text] [Related]  

  • 3. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
    Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer].
    Kushlinskiĭ NE; Liubimova NV; Lemeshko AO; Vasil'ev AV; Davydov MI
    Biull Eksp Biol Med; 1997 Jan; 123(1):98-100. PubMed ID: 9213472
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin].
    Rapellino M; Pecchio F; Cunazza M; Baldi S; Adamo MR; Casadio C; Faga C; Baldi C; Oliaro A; Albertino B
    Minerva Med; 1988 Dec; 79(12):1051-2. PubMed ID: 2850512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuron-specific enolase: a new marker for small-cell pulmonary carcinoma].
    Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Oliaro A; Pischedda F; Ardissone F
    Minerva Med; 1987 Apr; 78(7):465-7. PubMed ID: 3033550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuron specific enolase (NSE)].
    Odagiri E
    Nihon Rinsho; 1999 Dec; 57 Suppl():540-2. PubMed ID: 10778185
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuron specific enolase].
    Odagiri E
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():717-9. PubMed ID: 16149621
    [No Abstract]   [Full Text] [Related]  

  • 9. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron specific enolase in small cell lung cancer. Clinical and biochemical evaluation.
    Jørgensen LG
    Dan Med Bull; 1999 Feb; 46(1):1-12. PubMed ID: 10081650
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of cytoskeletal proteins in small cell lung carcinoma.
    Hlozánková M; Lukás Z; Viklický V
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():47-9. PubMed ID: 10707834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung.
    Springall DR; Lackie P; Levene MM; Marangos PJ; Polak JM
    J Pathol; 1984 Aug; 143(4):259-65. PubMed ID: 6090626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma.
    Sarandakou A; Poulakis N; Rizos D; Trakakis E; Phocas I
    Anticancer Res; 1993; 13(1):173-5. PubMed ID: 8386493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
    Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuron specific enolase].
    Milleron B
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S36-7. PubMed ID: 9229748
    [No Abstract]   [Full Text] [Related]  

  • 17. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of several tumor markers in the chest surgery].
    Miyazato I; Tojo N
    Rinsho Kyobu Geka; 1988 Jun; 8(3):231-6. PubMed ID: 9301836
    [No Abstract]   [Full Text] [Related]  

  • 20. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
    Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.